These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13395937)

  • 1. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine on acid-soluble phosphorus compounds, especially adenosintrophosphate and adenosindiphosphate in corneal tissue].
    MUNICH W
    Arzneimittelforschung; 1956 Dec; 6(12):729-31. PubMed ID: 13395937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies on the behavior of acid-soluble phosphorus compounds, especially of adenosine triphosphate and adenosine diphosphate in corneal tissues].
    MUNICH W
    Albrecht Von Graefes Arch Ophthalmol; 1957; 158(6):532-57. PubMed ID: 13435182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differentiation of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (phenylbutazone) and 3,5-dioxo-1,2-diphenyl-4-prenyl-pyrazolidine (prenazone) using reaction chromatography].
    schütz C; Schütz H
    Arzneimittelforschung; 1973 Mar; 23(3):428-31. PubMed ID: 4740130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical changes during the freezing of the cornea in vivo. A contribution to cryotherapy].
    Reim M; Schmidt F
    Klin Monbl Augenheilkd; 1967; 150(1):96-103. PubMed ID: 5598230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine effect potassium permeability in muscles?].
    GOHRING C; NETTER H
    Arzneimittelforschung; 1956 Dec; 6(12):734-6. PubMed ID: 13395939
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine. I. Distribution in organism after a single intravenous injection].
    HEISE ER; KIMBEL KH
    Arzneimittelforschung; 1956 Dec; 6(12):722-4. PubMed ID: 13395933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine on changes in irritability of the sciatic nerve and on tactile skin receptors].
    BAUST W; FISCHER T; SCHAEFER H
    Arzneimittelforschung; 1957 Sep; 7(9):547-50. PubMed ID: 13471398
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine in rats. II. Distribution of the drug in the organism after repeated oral doses].
    HEISE ER
    Arzneimittelforschung; 1956 Dec; 6(12):724-6. PubMed ID: 13395934
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of action of aminophenazone and 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine].
    VOELKEL A
    Arzneimittelforschung; 1956 Dec; 6(12):720-2. PubMed ID: 13395932
    [No Abstract]   [Full Text] [Related]  

  • 10. [Protein binding of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine and several other drugs].
    WUNDERLY C
    Arzneimittelforschung; 1956 Dec; 6(12):731-4. PubMed ID: 13395938
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral medication of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine and thyroid function].
    KLEIN E
    Arzneimittelforschung; 1956 Dec; 6(12):726-8. PubMed ID: 13395935
    [No Abstract]   [Full Text] [Related]  

  • 12. [Penetration of human aqueous humor by 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (butazolidin)].
    MUNICH W
    Albrecht Von Graefes Arch Ophthalmol; 1958; 160(2):181-5. PubMed ID: 13545132
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl pyrazolidine and 3,5-dioxo-1-phenyl-2-p-hydroxyphenyl-4-butyl pyrazolidine on the incorporation of C14-leucine into the blood plasma proteins of the isolated rat liver].
    JUNGBLUT PW
    Arzneimittelforschung; 1959 Sep; 9():549-51. PubMed ID: 14408193
    [No Abstract]   [Full Text] [Related]  

  • 14. [Distribution of acid-soluble phosphorus in the bovine corneal epithelium. Chemical and chromatographic study].
    DE BERARDINIS E
    Ann Ocul (Paris); 1961 Jan; 194():38-44. PubMed ID: 13720395
    [No Abstract]   [Full Text] [Related]  

  • 15. [The mechanism of action of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine; complex forming ability of this compound and effects on diphosphopyridine nucleotide-dependent zinc enzymes].
    WALLENFELS K; SUND H
    Arzneimittelforschung; 1959 Feb; 9(2):81-9. PubMed ID: 13638188
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine on phosphatases. 2].
    OHLMEYER P; KROMER H
    Arzneimittelforschung; 1958 Apr; 8(4):247-8. PubMed ID: 13535368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine on phosphatases].
    HAHN E; PLATE B
    Arzneimittelforschung; 1956 Dec; 6(12):728-9. PubMed ID: 13395936
    [No Abstract]   [Full Text] [Related]  

  • 18. [Painful shoulder: treatment by 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine].
    LEITAO A
    Hospital (Rio J); 1958 Sep; 54(3):335-8. PubMed ID: 13586748
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of carnosine and anserine on formation of rich in energy phosphorus compounds in the muscle tissue].
    MESHKOVA NP; ZAITSEVA NN
    Dokl Akad Nauk SSSR; 1953 Oct; 92(5):999-1002. PubMed ID: 13116903
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adenosintriphosphate, adenosindiphosphate and adenosinmonophosphate in cadaveric rigidity].
    FIORI A
    Minerva Medicoleg; 1957; 77(3):92-9. PubMed ID: 13493231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.